---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-005050"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:44:00.200040+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GoodRx CFO Karsten Voermann resigns; CAO Romin Nabiey named interim CFO

## Summary
- Karsten Voermann resigns as CFO effective Jan 17, 2025, for personal reasons, not due to any disagreement.
- Romin Nabiey, current Chief Accounting Officer, appointed Interim CFO and principal financial officer.
- Nabiey will continue as CAO; has been with GoodRx since 2017 in various finance roles.
- Voermann's vested stock options remain exercisable through Jan 17, 2026; he retains earned 2024 bonus.
- Company begins search for permanent CFO.

## SEC filing metadata
- accession: 0001193125-25-005050
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/0001193125-25-005050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/d926337d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-005050
- JSON: https://secwatch.observer/filing/0001193125-25-005050.json
- Plain text: https://secwatch.observer/filing/0001193125-25-005050.txt

## Key facts
- Executive change
  Romin Nabiey was appointed as Interim Chief Financial Officer at GoodRx Holdings, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: On January 10, 2025, the Board of Directors (the “Board”) of the Company appointed Romin Nabiey, the Company’s current Chief Accounting Officer, as Interim Chief Financial Officer of the Company, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/0001193125-25-005050-index.htm
- Executive change
  Karsten Voermann resigned as Chief Financial Officer at GoodRx Holdings, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On January 7, 2025, Karsten Voermann submitted his resignation as Chief Financial Officer of GoodRx Holdings, Inc. (the “Company”), effective January 17, 2025 (the “Effective Date”) for personal reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312525005050/0001193125-25-005050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.